Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ampelopsis radix extract is the crude extract derived from the dried root tuber of *Ampelopsis japonica* (Vitaceae), a traditional Chinese medicinal herb widely used in East Asia. It has been employed in traditional medicine primarily for its anti-inflammatory and anticancer properties, particularly in the management of colorectal cancer (CRC) and other malignancies[1]. Pharmacological studies have demonstrated that the extract exerts its effects via suppression of STAT3 signaling and Src phosphorylation, leading to reduced tumor cell viability, induction of apoptosis, and inhibition of cell migration[1]. It also possesses neuroprotective and antioxidant properties, partly due to its active polyphenolic constituents such as gallic acid, catechin, epicatechin, resveratrol, and schizandriside[1][3]. Recent research explores its use in advanced formulations, such as phytosome-encapsulated Ampelopsis radix ethanolic extracts, aiming to improve therapeutic efficacy against CRC[2]. Its mechanisms suggest potential in other indications involving inflammation and neurodegeneration, but modern drug derivatives or standardized pharmaceutical products are not yet available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ampelopsis radix extract.